UNSPSC 51284714: Sulfadiasulfone sodium

This classification denotes a sulfone anti-infective agent with the molecular formula C14H14N3O5S2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3M2Y4BU3, chemically known as 4, 4-diaminodiphenylsulfone-2-n-acetylsulfonamide, sodium but more generally known as acetosulfone sodium, which bears US NIH Compound Identifier 31400. European Medicines Agency schedules Sulfadiasulfone sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10694MIG.

The term SULFADIASULFONE SODIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). Most nations, for tariff and trade purposes, schedule sulfadiasulfone sodium under HS 29350090. SMILES: CC(=O)[N-]S(=O)(=O)C1CC(CCC1S(=O)(=O)C2CCC(CC2)N)N.[NA+].

UNSPSC 51284714 Sulfadiasulfone sodium is a Commodity code that captures pharmaceutical active ingredients and finished-form drugs procured through state and local health departments and county public health agencies. Recent state and local opportunities tagged under this code show acquisition of antibiotic tablets, naloxone, and drug deactivation systems—reflecting procurement activity across public health emergency response, disease prevention, and community health supply chains. Issuing bodies include state departments of public health and county health authorities.

Activity under the code concentrates in Illinois and Florida based on recent solicitations. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (IFB 26482DPHPREPDB53392, response date September 11, 2026) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11 over the full contract term including renewals. Seminole County, Florida issued an IFB (IFB60459723LAS, posted June 30, 2026, response date July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries required to the Seminole County Community Health Building in Sanford. Both opportunities emphasize vendor logistics compliance, E-Verify eligibility verification, and fixed-fee pricing structures.